Viewing Study NCT01319851


Ignite Creation Date: 2025-12-24 @ 11:47 PM
Ignite Modification Date: 2025-12-25 @ 9:41 PM
Study NCT ID: NCT01319851
Status: TERMINATED
Last Update Posted: 2017-07-27
First Post: 2010-09-15
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation
Sponsor: Emory University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Thalassemia View
None Sickle Cell Disease View
None Glanzmann Thrombasthenia View
None Wiskott-Aldrich Syndrome View
None Chronic-granulomatous Disease View
None Severe Congenital Neutropenia View
None Leukocyte Adhesion Deficiency View
None Schwachman-Diamond Syndrome View
None Diamond-Blackfan Anemia View
None Fanconi Anemia View
None Dyskeratosis-congenita View
None Chediak-Higashi Syndrome View
None Severe Aplastic Anemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None bone marrow transplant View
None sickle cell disease View
None thalassemia View
None Glanzmann thrombasthenia View
None Wiskott-Aldrich syndrome View
None chronic-granulomatous disease View
None severe congenital neutropenia View
None leukocyte adhesion deficiency View
None Schwachman-Diamond syndrome View
None Diamond-Blackfan anemia View
None Fanconi anemia View
None dyskeratosis-congenita View
None Chediak-Higashi syndrome View
None severe aplastic anemia View